Vista Pharmaceuticals (BOM:524711) EV-to-Revenue : 9.07 (As of May. 30, 2024)

View and export this data going back to 1994. Start your Free Trial

What is Vista Pharmaceuticals EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Vista Pharmaceuticals's enterprise value is ₹740.24 Mil. Vista Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₹81.59 Mil. Therefore, Vista Pharmaceuticals's EV-to-Revenue for today is 9.07.

The historical rank and industry rank for Vista Pharmaceuticals's EV-to-Revenue or its related term are showing as below:

BOM:524711' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.33 Med: 3.61 Max: 464.18
Current: 9.07

During the past 13 years, the highest EV-to-Revenue of Vista Pharmaceuticals was 464.18. The lowest was 0.33. And the median was 3.61.

BOM:524711's EV-to-Revenue is ranked worse than
86.59% of 1022 companies
in the Drug Manufacturers industry
Industry Median: 2.265 vs BOM:524711: 9.07

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-30), Vista Pharmaceuticals's stock price is ₹13.39. Vista Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₹1.82. Therefore, Vista Pharmaceuticals's PS Ratio for today is 7.35.

Vista Pharmaceuticals EV-to-Revenue Historical Data

The historical data trend for Vista Pharmaceuticals's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vista Pharmaceuticals EV-to-Revenue Chart

Vista Pharmaceuticals Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

EV-to-Revenue

Get a 7-Day Free Trial

2.32

1.38

34.66

117.75

41.06

Vista Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															-	41.06	14.08	13.37	8.43

Competitive Comparison of Vista Pharmaceuticals's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Vista Pharmaceuticals's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vista Pharmaceuticals's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vista Pharmaceuticals's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Vista Pharmaceuticals's EV-to-Revenue falls into.

Vista Pharmaceuticals EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Vista Pharmaceuticals's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	740.236	/	81.59
	=	9.07

Vista Pharmaceuticals's current Enterprise Value is ₹740.24 Mil.
Vista Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹81.59 Mil.

Vista Pharmaceuticals (BOM:524711) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Vista Pharmaceuticals's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	13.39	/	1.822
	=	7.35

Vista Pharmaceuticals's share price for today is ₹13.39.
Vista Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1.82.

Vista Pharmaceuticals EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Vista Pharmaceuticals's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Vista Pharmaceuticals (BOM:524711) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vista Pharmaceuticals Ltd (BOM:524711) » Definitions » EV-to-Revenue

Traded in Other Exchanges

N/A

Address

Plot No. 104, Kakateeya Hills, Ravindra Co OP Society Guttala Begumpet, Hyderabad, TG, IND, 500033

Website

http://www.vistapharmaceuticals.com

Vista Pharmaceuticals Ltd is an Indian based company engaged in single operating segments that is the manufacturing of Pharmaceutical products. The company offers over the counter and prescription generic drug products such as tablets, capsules, and liquids covering various therapeutic categories. Some of the drugs in tablet dosage forms are Sulfamethoxazole and Trimethoprim, Bismuth Subgallate, Pyrantel Pamoate, Aspirin, Ibuprofen, Ranitidine HCl, and others. Nifedipine, Piroxicam, Indomethacin are the drugs offered by the company in a capsule dosage form. The business is carried out in India.

Vista Pharmaceuticals (BOM:524711) Headlines

No Headlines